Toradol (ketorolac) is available in several forms, including injection, oral tablets, nasal spray, and ophthalmic drops. Pricing varies widely depending on the formulation, dosage strength, manufacturer, pharmacy, and country. Injectable Toradol is typically the most expensive due to clinical‑grade packaging and hospital‑level use, while oral tablets are generally the most affordable option for short‑term outpatient therapy.
This page provides a clear, structured overview of Toradol pricing across all major forms to help you understand typical cost ranges before purchasing. For detailed information on specific formulations, see the Toradol injection and Toradol tablets pages. This is a pricing overview, not a medical recommendation.
Toradol (ketorolac) pricing varies widely depending on formulation, dosage strength, manufacturer, region, and pharmacy markup. Because Toradol is available in multiple forms — including injection, oral tablets, nasal spray, and ophthalmic drops — each format has its own cost structure. Injectable ketorolac is typically the most expensive due to clinical‑ grade packaging and hospital‑level use, while tablets are generally the most affordable. Insurance coverage may reduce the cost, but this varies by country and provider.
The form of Toradol has the strongest impact on price. Injections (IM/IV) cost more because they require sterile manufacturing, specialized packaging, and are often used in clinical settings. Higher doses such as 30 mg and 60 mg injections are priced above 15 mg versions. Oral tablets (typically 10 mg) are cheaper due to simpler production and wider availability. Nasal spray and ophthalmic drops fall in the mid‑to‑high range due to specialized delivery systems.
Toradol is the brand name, while ketorolac is the generic equivalent. Generic ketorolac is significantly cheaper because it does not carry brand‑level marketing or development costs. In most regions, generic ketorolac offers the same active ingredient and therapeutic effect at a lower price, making it the more economical option for both injections and tablets.
Toradol injection (ketorolac tromethamine IM/IV) is the most expensive form of the medication due to its clinical use, sterile manufacturing requirements, and hospital‑grade packaging. It is available in several strengths, most commonly 15 mg, 30 mg, and 60 mg. Higher‑dose vials typically cost more because they are used in acute care settings where rapid, potent analgesia is required.
The 30 mg formulation is the most widely used and often priced higher than the 15 mg dose due to demand and clinical preference. More details are available on the Ketorolac 30 mg injection page. The 60 mg formulation is typically the most expensive per vial because it is used in more severe pain scenarios and contains double the active ingredient. See the Ketorolac 60 mg injection page for specifics.
Toradol injections are commonly used in hospitals, surgical centers, and emergency departments, which contributes to higher pricing due to medical‑grade distribution channels. Retail pharmacies may also carry injectable ketorolac, but prices vary depending on region, insurance coverage, and pharmacy markup.
Overall, Toradol injection is the costliest form of ketorolac, reflecting its potency, clinical utility, and manufacturing complexity.
Toradol tablets (ketorolac oral) are typically the most affordable form of the medication. The standard dosage is 10 mg, and tablets are widely available in both brand and generic versions. Pricing varies depending on package size, manufacturer, and pharmacy markup, but oral ketorolac consistently remains cheaper than injectable forms.
The cost per tablet is generally low because oral formulations require simpler production processes and do not involve sterile manufacturing. Generic ketorolac tablets offer the lowest price point, making them a cost‑effective option for short‑term outpatient therapy. More details are available on the Toradol oral page.
Toradol tablets are often used as continuation therapy after an initial injection, which also contributes to their lower cost. They are widely stocked in retail pharmacies, making pricing more competitive compared with hospital‑only formulations.
Overall, Toradol tablets provide the most economical way to access ketorolac for short‑term pain management.
Toradol nasal spray is a less common formulation of ketorolac and is typically priced higher than tablets due to its specialized delivery system. The nasal route allows rapid absorption without injection, making it useful for patients who require fast relief but prefer a non‑invasive option.
Because nasal sprays require advanced manufacturing technology and smaller production volumes, their price is generally higher than oral formulations. Availability may also vary by region, which can further influence cost. More details are available on the Toradol nasal spray page.
Toradol nasal spray is often used in outpatient settings or for patients who cannot take oral medications, contributing to its higher price point.
Acular is the ophthalmic form of ketorolac, used for eye inflammation and postoperative ocular pain. It is typically sold as a small bottle of sterile eye drops, and pricing depends on the specific formulation: Acular, Acular LS, and Acuvail. Each version differs in concentration, preservative content, and intended use.
Acular LS is a lower‑strength formulation designed for patients who require reduced irritation, while Acuvail is a preservative‑free version often priced higher due to its advanced formulation. More details are available on the Acular ketorolac page.
Ophthalmic ketorolac is generally priced higher per milliliter than oral formulations due to sterile manufacturing, specialized packaging, and smaller production volumes.
Toradol is the brand name for ketorolac, while generic ketorolac is produced by multiple manufacturers at a lower cost. The price difference between brand and generic versions can be significant, especially for injections and ophthalmic formulations.
Generic ketorolac is cheaper because it does not carry brand‑level marketing, development, or distribution costs. It contains the same active ingredient and is required to meet the same regulatory standards for quality and efficacy. For most patients, generic ketorolac provides identical therapeutic value at a fraction of the price.
Brand‑name Toradol may still be preferred in certain clinical settings due to familiarity or institutional purchasing agreements, but for retail consumers, generic ketorolac is almost always the more economical choice.
Toradol pricing varies significantly across global regions due to differences in healthcare systems, insurance coverage, regulatory frameworks, and pharmacy markups. In the United States, Toradol injection and ophthalmic formulations tend to be more expensive due to higher healthcare costs and insurance‑based pricing models. Generic ketorolac tablets are more affordable but still vary widely by pharmacy.
In Canada, prices are generally lower due to government‑regulated drug costs, though availability of certain formulations may be more limited. Europe typically offers moderate pricing, with strong generic competition reducing the cost of oral ketorolac. Hospital‑only formulations such as injections may still be priced higher depending on the country.
In Asia, pricing varies dramatically by country. Some regions offer very low prices for generic ketorolac, while others have higher costs due to importation or limited local manufacturing.
Overall, Toradol pricing reflects regional healthcare structures, regulatory environments, and market competition.
| Form | Dosage | Price (Range) | Use Setting |
|---|---|---|---|
| Injection | 15 mg | varies by region | Hospital / Clinic |
| Injection | 30 mg | varies by region | Hospital / Clinic |
| Injection | 60 mg | varies by region | Hospital / Clinic |
Toradol injections are the most expensive form of ketorolac due to sterile manufacturing, clinical‑grade packaging, and hospital‑level distribution. Prices vary depending on dosage, with 30 mg and 60 mg vials typically costing more due to higher potency and demand in surgical and emergency settings. Injection pricing also varies by country, pharmacy markup, and insurance coverage.
| Form | Dosage | Price (Range) | Price per Tablet |
|---|---|---|---|
| Tablets | 10 mg | varies by region | varies by region |
Toradol tablets are the most affordable form of ketorolac. The standard 10 mg dosage is widely available in both brand and generic versions. Prices vary depending on package size, manufacturer, and pharmacy markup. Cost per tablet is typically low, making oral ketorolac the most economical option for short‑term outpatient therapy.
| Form | Price | Notes |
|---|---|---|
| Nasal spray | varies by region | Fast onset |
Toradol nasal spray is a rare formulation and is typically priced higher than tablets due to its specialized delivery system. It offers rapid absorption without injection, making it useful for patients who need fast relief but prefer a non‑invasive option. Limited availability and advanced manufacturing contribute to its higher cost.
| Form | Concentration | Price | Notes |
|---|---|---|---|
| Acular | 0.5% | varies by region | Standard |
| Acular LS | 0.4% | varies by region | Milder |
| Acuvail | 0.45% | varies by region | Preservative‑free |
Acular and its variants (Acular LS, Acuvail) differ in concentration and formulation. Preservative‑free versions like Acuvail are typically more expensive due to advanced manufacturing. Ophthalmic ketorolac is priced higher per milliliter than oral forms because of sterile production and specialized packaging.
| Type | Price | Comment |
|---|---|---|
| Toradol (brand) | Higher | Brand‑name product |
| Ketorolac (generic) | Lower | Equivalent formulation |
Brand‑name Toradol is consistently more expensive due to marketing, distribution, and brand recognition. Generic ketorolac contains the same active ingredient and is required to meet identical quality standards, making it a more economical option. The price gap is most noticeable in injections and ophthalmic formulations.
Toradol can be relatively expensive compared with other NSAIDs due to several factors. Injectable ketorolac requires sterile manufacturing, specialized packaging, and clinical‑ grade distribution, all of which increase production costs. Because injections are used in hospitals, surgical centers, and emergency departments, pricing often reflects institutional procurement models rather than retail pharmacy pricing.
Toradol’s high potency also contributes to its cost. As one of the strongest non‑opioid analgesics, it is used in acute care settings where rapid, reliable pain control is essential. This clinical value increases demand for injectable and ophthalmic forms, which tend to be priced higher.
Brand‑name Toradol is more expensive than generic ketorolac due to branding, marketing, and distribution costs. In contrast, generic versions are widely available and significantly cheaper, especially for tablets.
Overall, Toradol’s price reflects its potency, clinical utility, and the complexity of manufacturing certain formulations.
Comparing Toradol prices effectively requires looking beyond the total cost of a package. The most important metric is the price per dose — for example, the cost per 10 mg tablet or per 30 mg injection. This allows accurate comparison across pharmacies, regions, and manufacturers.
For injectable ketorolac, price per milliliter is a useful metric because vials vary in size and concentration. A 30 mg/mL vial may appear more expensive than a 15 mg vial, but the cost per milligram may be lower. For ophthalmic forms like Acular, price per milliliter is also the most accurate comparison method.
For tablets, price per tablet is the simplest and most reliable metric. Generic ketorolac tablets typically offer the lowest cost per dose, while brand‑name Toradol tablets are priced higher.
Evaluating price per dose, per milliliter, or per tablet ensures a clear, accurate comparison across all Toradol formulations.